Search earnings tickers

VRTX

2025Q2AMC

Vertex Pharmaceuticals Inc primary · HEALTHCARE · BIOTECHNOLOGY

Report 2025-08-04 · Fiscal end 2025-06-30 · Features as of 2025-08-04

← Earnings history

Street

Consensus EPS4.25

Consensus rev—

EPS high—

EPS low—

Dispersion—

Analysts—

EPS rev net 7d—

EPS rev net 30d—

Consensus Δ 7d—

Consensus Δ 30d—

Options

Implied move2.7%

IV front—

P/C full—

P/C front—

Features as of2025-08-04

Run-up

Close—

Ret 5d+2.5%

Ret 10d+3.0%

Ret 20d+2.8%

Ret 30d+7.1%

Print

Actual EPS

4.52Beat

Estimated EPS4.25

Actual revenue

3.0B

Surprise %+6.4%

Beat / missBeat

Beat streak 41

Beat streak 81

Reaction

1-day stock reaction-8.1%

Implied vs actual

Implied 2.7%Actual 13.6%

Gap reaction-13.6%

Day result-20.6%

Next-day upNo

Realized / IV5.01×

Post tape

Post 5d+3.4%

Post 10d+4.2%

Post volume10.7M

Vol ×10d7.71×

Vol ×20d9.16×

Post range10.2%